Our medical, nursing and allied health clinicians are increasingly involved in research to improve the care of our patients. This is reflected in the breadth of our research publications.
Combined beta-glucosylceramide and ambroxol hydrochloride in patients with Gaucher related Parkinson disease: From clinical observations to drug development
Ishay, Y; Zimran, A; Szer, J; Dinur, T; Ilana, Y; Arkadir, D
(2018), Blood Cells Mol. Dis., 117-120
Assessment of Impact of HLA Type on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
Hill, BT; Ahn, KW; Hu, ZH; Aljurf, M; Beitinjaneh, A; Cahn, JY; Cerny, J; Kharfan-Dabaja, MA; Ganguly, S; Ghosh, N; Grunwald, MR; Inamoto, Y; Kindwall-Keller, T; Nishihori, T; Olsson, RF; Saad, A; Seftel, M; Seo, S; Szer, J; Tallman, M; Ustun, C; Wiernik, PH; Maziarz, RT; Kalaycio, M; Alyea, E; Popat, U; Sobecks, R; Saber, W
(2018), Biol. Blood Marrow Transplant., 581-586
Immunochemotherapy With Obinutuzumab or Rituximab for Previously Untreated Follicular Lymphoma in the GALLIUM Study: Influence of Chemotherapy on Efficacy and Safety
Hiddemann, W; Barbui, AM; Canales, MA; Cannell, PK; Collins, GP; Durig, J; Forstpointner, R; Herold, M; Hertzberg, M; Klanova, M; Radford, J; Seymour, JF; Tobinai, K; Trotman, J; Burciu, A; Fingerle-Rowson, G; Wolbers, M; Nielsen, T; Marcus, RE
(2018), J. Clin. Oncol., 2395-+
Activating killer-cell immunoglobulin-like receptor haplotype influences clinical outcome following HLA-matched sibling haematopoietic stem cell transplantation
Heatley, SL; Mullighan, CG; Doherty, K; Danner, S; O'Connor, GM; Hahn, U; Szer, J; Schwarer, A; Bradstock, K; Sullivan, LC; Bardy, PG; Brooks, AG
(2018), HLA, 74-82
DOI: 10.1111/tan.13327
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Hallek, M; Cheson, BD; Catovsky, D; Caligaris-Cappio, F; Dighiero, G; Dohner, H; Hillmen, P; Keating, M; Montserrat, E; Chiorazzi, N; Stilgenbauer, S; Rai, KR; Byrd, JC; Eichhorst, B; O'Brien, S; Robak, T; Seymour, JF; Kipps, TJ
(2018), Blood, 2745-2760
Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care
Dohner, H; Dolnik, A; Tang, L; Seymour, JF; Minden, MD; Stone, RM; del Castillo, TB; Al-Ali, HK; Santini, V; Vyas, P; Beach, CL; MacBeth, KJ; Skikne, BS; Songer, S; Tu, N; Bullinger, L; Dombret, H
(2018), Leukemia, 2546-2557
Azacitidine with or without eltrombopag for first-line treatment of intermediate- or high-risk MDS with thrombocytopenia
Dickinson, M; Cherif, H; Fenaux, P; Mittelman, M; Verma, A; Portella, MSO; Burgess, P; Ramos, PM; Choi, J; Platzbecker, U
(2018), Blood, 2629-2638
Revised Dose Ramp-Up to Mitigate the Risk of Tumor Lysis Syndrome When Initiating Venetoclax in Patients With Mantle Cell Lymphoma
Davids, MS; von Keudell, G; Portell, CA; Cohen, JB; Fisher, DC; Foss, F; Roberts, AW; Seymour, JF; Humerickhouse, RA; Tam, CS
(2018), J. Clin. Oncol., 3525-+
DOI: 10.1200/JCO.18.00359
Comprehensive Safety Analysis of Venetoclax Monotherapy for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Davids, MS; Hallek, M; Wierda, W; Roberts, AW; Stilgenbauer, S; Jones, JA; Gerecitano, JF; Kim, SY; Potluri, J; Busman, T; Best, A; Verdugo, ME; Cerri, E; Desai, M; Hillmen, P; Seymour, JF
(2018), Clin. Cancer Res., 4371-4379
Characterization of Tfrc-mutant mice with microcytic phenotypes
Conway, AJ; Brown, FC; Rank, G; Kile, BT; Morton, CJ; Jane, SM; Curtis, DJ
(2018), Blood Adv., 1914-1922
Red blood cell specifications for patients with hemoglobinopathies: a systematic review and guideline
Compernolle, V; Chou, ST; Tanael, S; Savage, W; Howard, J; Josephson, CD; Odame, I; Hogan, C; Denomme, G; Shehata, N
(2018), Transfusion, 1555-1566
DOI: 10.1111/trf.14611
Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04)
Coleman, RE; Collinson, M; Gregory, W; Marshall, H; Bell, R; Dodwell, D; Keane, M; Gil, M; Barrett-Lee, P; Ritchie, D; Bowman, A; Liversedge, V; De Boer, RH; Passos-Coelho, JL; O'Reilly, S; Bertelli, G; Joffe, J; Brown, JE; Wilson, C; Tercero, JC; Jean-Mairet, J; Gomis, R; Cameron, D
(2018), J. Bone Oncol., 123-135
Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosis
Chua, CC; Omerod, A; Wight, J; Juneja, S; Zantomio, D
(2018), Pathology, 671-674
Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma
Chua, CC; Lim, HY; Chai, KL; Ong, J; Sim, S; Wood, C; Dickinson, M; Campbell, P; Hempton, J; King, H; Dowsing, C; Bergin, K; Muir, S; Gibbs, S; Grigg, A
(2018), Bone Marrow Transplant., 1116-1123
The impact and indications for Oncotype DX on adjuvant treatment recommendations when third-party funding is unavailable
Chin-Lenn, L; De Boer, RH; Segelov, E; Marx, GM; Hughes, TM; McCarthy, NJ; White, SC; Foo, SS; Rutovitz, JJ; Della-Fiorentina, S; Jennens, R; Antill, YC; Tsoi, D; Cronk, MF; Lombard, JM; Kiely, BE; Chirgwin, JH; Gorelik, A; Mann, GB
(2018), Asia-Pac. J. Clin. Oncol., 410-416
DOI: 10.1111/ajco.13075
AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies
Caenepeel, S; Brown, SP; Belmontes, B; Moody, G; Keegan, KS; Chui, D; Whittington, DA; Huang, X; Poppe, L; Cheng, AC; Cardozom, M; Houze, J; Li, YX; Lucas, B; Paras, NA; Wang, XH; Taygerly, JP; Vimolratana, M; Zancanella, M; Zhu, LS; Cajulis, E; Osgood, T; Sun, J; Damon, L; Egan, RK; Greninger, P; McClanaghan, JD; Gong, JN; Moujalled, D; Pomilio, G; Beltran, P; Benes, CH; Roberts, AW; Huang, DC; Wei, A; Canon, J; Coxon, A; Hughes, PE
(2018), Cancer Discov., 1582-1597
Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT
Buchbinder, D; Kelly, DL; Duarte, RF; Auletta, JJ; Bhatt, N; Byrne, M; DeFilipp, Z; Gabriel, M; Mahindra, A; Norkin, M; Schoemans, H; Shah, AJ; Ahmed, I; Atsuta, Y; Basak, GW; Beattie, S; Bhella, S; Bredeson, C; Bunin, N; Dalal, J; Daly, A; Gajewski, J; Gale, RP; Galvin, J; Hamadani, M; Hayashi, RJ; Adekola, K; Law, J; Lee, CJ; Liesveld, J; Malone, AK; Nagler, A; Naik, S; Nishihori, T; Parsons, SK; Scherwath, A; Schofield, HL; Soiffer, R; Szer, J; Twist, I; Warwick, AB; Wirk, BM; Yi, J; Battiwalla, M; Flowers, MDE; Savani, B; Shaw, BE
(2018), Bone Marrow Transplant., 535-555
Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
Biegstraaten, M; Cox, TM; Belmatoug, N; Berger, MG; Collin-Histed, T; Dahl, SV; Di Rocco, M; Fraga, C; Giona, F; Giraldo, P; Hasanhodzic, M; Hughes, DA; Iversen, PO; Kiewiet, AI; Lukina, E; Machaczka, M; Marinakis, T; Mengel, E; Pastores, GM; Plockinger, U; Rosenbaum, H; Serratrice, C; Symeonidis, A; Szer, J; Timmerman, J; Tylki-Szymanska, A; Hubshman, MW; Zafeiriou, DI; Zimran, A; Hollak, CEM
(2018), Blood Cells Mol. Dis., 203-208
Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model
Bellgard, MI; Napier, KR; Bittles, AH; Szer, J; Fletcher, S; Zeps, N; Hunter, AA; Goldblatt, J
(2018), Blood Cells Mol. Dis., 232-238
Absence of renal phenotype in hereditary haemorrhagic telangiectasia
Healy, L; Nicholls, K; Gibson, R; Stella, D; Bogwitz, M; Taylor, J; Walsh, M; Donaldson, L; Winship, I
(2018), Intern. Med. J., 1255-1257
DOI: 10.1111/imj.14059
The use of a risk assessment and decision support tool (CRISP) compared with usual care in general practice to increase risk-stratified colorectal cancer screening: study protocol for a randomised controlled trial
Walker, JG; Macrae, F; Winship, I; Oberoi, J; Saya, S; Milton, S; Bickerstaffe, A; Dowty, JG; Lourenco, RD; Clark, M; Galloway, L; Fishman, G; Walter, FM; Flander, L; Chondros, P; Ouakrim, DA; Pirotta, M; Trevena, L; Jenkins, MA; Emery, JD
(2018), Trials
Mutations in SUFU and PTCH1 genes may cause different cutaneous cancer predisposition syndromes: similar, but not the same
Huq, AJ; Walsh, M; Rajagopalan, B; Finlay, M; Trainer, AH; Bonnet, F; Sevenet, N; Winship, IM
(2018), Fam. Cancer, 601-606
Family history-based colorectal cancer screening in Australia: A modelling study of the costs, benefits, and harms of different participation scenarios
Dillon, M; Flander, L; Buchanan, DD; Macrae, FA; Emery, JD; Winship, IM; Boussioutas, A; Giles, GG; Hopper, JL; Jenkins, MA; Ouakrim, DA
(2018), PLos Med.
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1
Buchanan, DD; Stewart, JR; Clendenning, M; Rosty, C; Mahmood, K; Pope, BJ; Jenkins, MA; Hopper, JL; Southey, MC; Macrae, FA; Winship, IM; Win, AK
(2018), Genet. Med., 890-895
DOI: 10.1038/gim.2017.185
Spotlight on the utility of the Oncotype DX (R) breast cancer assay
Siow, ZR; De Boer, RH; Lindeman, GJ; Mann, GB
(2018), Int. J. Womens Health, 89-100
DOI: 10.2147/IJWH.S124520
No live vaccines for people being treated with leflunomide Reply
Wong, PKK; Hanrahan, P; Johnson, DF
(2018), Intern. Med. J., 1280-1281
DOI: 10.1111/imj.14053
Cancer Risks for PMS2-Associated Lynch Syndrome
ten Broeke, SW; van der Klift, HM; Tops, CMJ; Aretz, S; Bernstein, I; Buchanan, DD; de la Chapelle, A; Capella, G; Clendenning, M; Engel, C; Gallinger, S; Gomez Garcia, E; Figueiredo, JC; Haile, R; Hampel, HL; Hopper, JL; Hoogerbrugge, N; Doeberitz, MV; Le Marchand, L; Letteboer, TGW; Jenkins, MA; Lindblom, A; Lindor, NM; Mensenkamp, AR; Moller, P; Newcomb, PA; van Os, TAM; Pearlman, R; Pineda, M; Rahner, N; Redeker, EJW; Olderode-Berends, MJW; Rosty, C; Schackert, HK; Scott, R; Senter, L; Spruijt, L; Steinke-Lange, V; Suerink, M; Thibodeau, S; Vos, YJ; Wagner, A; Winship, I; Hes, FJ; Vasen, HFA; Wijnen, JT; Nielsen, M; Win, AK
(2018), J. Clin. Oncol., 2961-+
Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations
Rebbeck, TR; Friebel, TM; Friedman, E; Hamann, U; Huo, DZ; Kwong, A; Olah, E; Olopade, OI; Solano, AR; Teo, SH; Thomassen, M; Weitzel, JN; Chan, TL; Fergus, J; Goldgar, DE; Kruse, TA; Edenir, I; Park, SK; Torres, D; van Rensburg, EJ; McGuffog, L; Parsons, MT; Leslie, G; Aalfs, CM; Abugattas, J; Adlard, J; Agata, S; Aittomaki, K; Andrews, L; Andrulis, IL; Arason, A; Arnold, N; Arun, BK; Asseryanis, E; Auerbach, L; Azzollini, J; Balmana, J; Barile, M; Barkardottir, RB; Barrowdale, D; Benitez, J; Berger, A; Berger, R; Blanco, AM; Blazer, KR; Blok, MJ; Bonadona, V; Bonanni, B; Bradbury, AR; Brewer, C; Buecher, B; Buys, SS; Caldes, T; Caliebe, A; Caligo, MA; Campbell, I; Caputo, SM; Chiquette, J; Chung, WK; Claes, KBM; Collee, JM; Cook, J; Davidson, R; de la Hoya, M; De Leeneer, K; de Pauw, A; Delnatte, C; Diez, O; Ding, YC; Ditsch, N; Domchek, S; Dorfling, CM; Velazquez, C; Dworniczak, B; Eason, J; Easton, DF; Eeles, R; Ehrencrona, H; Ejlertsen, B; Engel, C; Engert, S; Evans, DG; Faivre, L; Feliubadalo, L; Ferrer, SF; Foretova, L; Fowler, J; Frost, D; Galvao, HCR; Ganz, PA; Garber, J; Gauthier-Villars, M; Gehrig, A; Gerdes, AM; Gesta, P; Giannini, G; Giraud, S; Glendon, G; Godwin, AK; Greene, MH; Gronwald, J; Gutierrez-Barrera, A; Hahnen, E; Hauke, J; Henderson, A; Hentschel, J; Hogervorst, FBL; Honisch, E; Imyanitov, EN; Isaacs, C; Izatt, L; Izquierdo, A; Jakubowska, A; James, P; Janavicius, R; Jensen, UB; John, EM; Vijai, J; Kaczmarek, K; Karlan, BY; Kast, K; Kim, SW; Konstantopoulou, I; Korach, J; Laitman, Y; Lasa, A; Lasset, C; Lazaro, C; Lee, A; Lee, MH; Lester, J; Lesueur, F; Liljegren, A; Lindor, NM; Longy, M; Loud, JT; Lu, KH; Lubinski, J; Machackova, E; Manoukian, S; Mari, V; Martinez-Bouzas, C; Matrai, Z; Mebirouk, N; Meijers-Heijboer, HEJ; Meindl, A; Mensenkamp, AR; Mickys, U; Miller, A; Montagna, M; Moysich, KB; Mulligan, AM; Musinsky, J; Neuhausen, SL; Nevanlinna, H; Ngeow, J; Nguyen, HP; Niederacher, D; Nielsen, HR; Nielsen, FC; Nussbaum, RL; Offit, K; Ofverholm, A; Ong, KR; Osorio, A; Papi, L; Papp, J; Pasini, B; Pedersen, IS; Peixoto, A; Peruga, N; Peterlongo, P; Pohl, E; Pradhan, N; Prajzendanc, K; Prieur, F; Pujol, P; Radice, P; Ramus, SJ; Rantala, J; Rashid, MU; Rhiem, K; Robson, M; Rodriguez, GC; Rogers, MT; Rudaitis, V; Schmidt, AY; Schmutzler, RK; Senter, L; Shah, PD; Sharma, P; Side, LE; Simard, J; Singer, CF; Skytte, AB; Slavin, TP; Snape, K; Sobol, H; Southey, M; Steele, L; Steinemann, D; Sukiennicki, G; Sutter, C; Szabo, CI; Tan, YY; Teixeira, MR; Terry, MB; Teule, A; Thomas, A; Thull, DL; Tischkowitz, M; Tognazzo, S; Toland, AE; Topka, S; Trainer, AH; Tung, N; van Asperen, CJ; van der Hout, AH; van der Kolk, LE; van der Luijt, RB; Van Heetvelde, M; Varesco, L; Varon-Mateeva, R; Vega, A; Villarreal-Garza, C; von Wachenfeldt, A; Walker, L; Wang-Gohrke, S; Wappenschmidt, B; Weber, BHF; Yannoukakos, D; Yoon, SY; Zanzottera, C; Zidan, J; Zorn, KK; Selkirk, CGH; Hulick, PJ; Chenevix-Trench, G; Spurdle, AB; Antoniou, AC; Nathanson, KL
(2018), Hum. Mutat., 593-620
DOI: 10.1002/humu.23406
Heterogeneity and Uncertainties Specific to Genome-Based Health Technological Assessments
Petelin, L; Liew, D; Mitchell, G; James, PA; Trainer, AH
(2018), Value Health, 891-893
Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia
Petelin, L; James, PA; Trainer, AH
(2018), Intern. Med. J., 1269-+
DOI: 10.1111/imj.14058